AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with four product candidates in cl...
0 entries
0 comments
Building
Building B
Address
EPFL Innovation Park Building B 1015 Lausanne
Name
AC Immune SA
Company Type
Start-up / SME
Phone
+41 21 345 91 21
Email
info@acimmune.com
About / Bio / Mission
AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with four product candidates in clinical trials. The Company designs, discovers and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. AC Immune’s two proprietary technology platforms create antibodies, small molecules and vaccines designed to address a broad spectrum of neurodegenerative indications, such as Alzheimer’s disease. The Company’s pipeline features seven therapeutic and three diagnostic product candidates. The most advanced of these is crenezumab, an anti-Abeta antibody in Phase 3 clinical studies, that is being advanced by our collaboration partner Genentech, Inc., a member of the Roche group. Other partners include Biogen, Janssen Pharmaceuticals, Nestlé Institute of Health Science, Piramal Imaging.
Sectors
Biotech
Activity Keywords
Alzheimer, protein misfolding, CNS, therapeutics, Crenezumab, diagnostics, prevention, vaccine, small molecules, antibodies, Abeta, Tau
Partners
Genentech, Janssen, Nestlé Institute of Health Science, Piramal Imaging,
Is an EPFL spin-off
no
Is an Alumni
no
Jobs Offers